Substituted urea derivatives for treating cardiac diseases

Details for Australian Patent Application No. 2011253934 (hide)

Owner Cytokinetics, Inc.

Inventors Morgan, Bradley P.; Muci, Alex; Lu, PuPing; Kraynack, Erica; Tochimoto, Todd; Morgans, David

Agent Davies Collison Cave

Pub. Number AU-A-2011253934

Parent 2005264988

Filing date 9 December 2011

Wipo publication date 12 January 2012

International Classifications

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/42 (2006.01) - Oxazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 January 2012 Application Open to Public Inspection

  Published as AU-A-2011253934

12 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011253935-Improved pool circulation systems

2011253933-Monoclonal antibodies that specifically bind to folate receptor alpha